2019
DOI: 10.1016/j.neuroscience.2019.06.026
|View full text |Cite
|
Sign up to set email alerts
|

Presynaptic Dysfunction in Neurons Derived from Tay–Sachs iPSCs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 21 publications
(10 citation statements)
references
References 36 publications
0
10
0
Order By: Relevance
“…In humans, a well-established NGT-binding protein is the lysosomal enzyme hexosaminidase A (HEXA). HEXA activity is linked to autophagy and mutations in HEXA cause the lysosomal storage disorder Tay-Sachs disease ( Okada and O’Brien, 1969 ; Urbanelli et al, 2014 ; Matsushita et al, 2019 ). HEXA, CLN5, and Dictyostelium Cln5 all have glycoside hydrolase activity ( Okada and O’Brien, 1969 ; Huber and Mathavarajah, 2018a ).…”
Section: Resultsmentioning
confidence: 99%
“…In humans, a well-established NGT-binding protein is the lysosomal enzyme hexosaminidase A (HEXA). HEXA activity is linked to autophagy and mutations in HEXA cause the lysosomal storage disorder Tay-Sachs disease ( Okada and O’Brien, 1969 ; Urbanelli et al, 2014 ; Matsushita et al, 2019 ). HEXA, CLN5, and Dictyostelium Cln5 all have glycoside hydrolase activity ( Okada and O’Brien, 1969 ; Huber and Mathavarajah, 2018a ).…”
Section: Resultsmentioning
confidence: 99%
“…S9E). Structural changes of synaptic sites in hippocampal neurons normally occur at the onset of a worsening phenotype and are concomitant with lysosomal enlargement, which is characteristic of overt lysosomal dysfunction [30][31][32][33]. Because of the effect of the observed lysosomal dysfunction on synaptic structure and synaptic function, we examined the ultra-structural changes in the synaptic machinery to identify the relevant structures impacted by the lysosomal dysfunction.…”
Section: The Effects Of Autophagy and Lysosome Dysfunction On Synaptimentioning
confidence: 99%
“…Pathogenic variants in the HEXA-encoding gene leads to impaired activity of the enzyme, which loses its ability to cleave the terminal N-acetyl hexosamine residues of fatty acid derivatives known as GM2 gangliosides. As a result, N-acetyl hexosamine residues are massively accumulated in neuronal cells instead of further metabolizing into GM3 gangliosides [2]. Clinical features of the disease include seizures, hypotonia, weakness, regression of motor milestones, maculopathy with 'cherry-red spot', and cognitive deficits.…”
Section: Zusammenfassungmentioning
confidence: 99%